It was reported that trials of an Oxford University coronavirus vaccine had been put on hold after a participant experienced a serious adverse reaction.
Cruise 1323 has received confirmation of the real reason why the trials were halted.
A spokesperson for AstraZeneca said:
“As part of the ongoing randomised, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee.
“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.
“In large trials illnesses will happen by chance but must be independently reviewed to check this carefully. We are working to expedite the review of the single event to minimise any potential impact on the trial timeline.
“We are committed to the safety of our participants and the highest standards of conduct in our trials.”